RBI Recruitment 2025: Application For Medical Consultant Ends Tomorrow, Check How To Apply
RBI Recruitment 2025: The Reserve Bank of India (RBI) has announced the closing date for applications for the position of ...
Colorectal and Pelvic Reconstructive Service at Melbourne's Royal Children's Hospital to close
The Colorectal and Pelvic Reconstructive Service at the Royal Children's Hospital in Melbourne is closing as a $5.9 million ...
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option
Drugs Made In America Acquisition Corp. (Nasdaq: DMAAU) (the “Company”) today announced that the underwriter of its previously announced initial public offering fully exercised its option to purchase ...
Taiwan News15d
SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market
DENVER, Feb. 03, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) today announced the closing of its previously announced ... to a shelf registration ...
KSNW Wichita on MSN14d
Kansas pharmacies closing temporarily so they don’t close forever
The Kansas Pharmacists Association says 10 pharmacies closed last year in Kansas, one already this year. To some, it’s a ...
“We Will Fight Back”: Aid Workers Fear Closing a Camp on the Arizona Border Will Endanger Migrants
For the past two years, religious and humanitarian organizations have provided food and aid to migrants at a camp near Sasabe ...
Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 6,103,289 shares of the Company’s common stock at a purchase price of ...
Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option
FORT LEE, NJ, Feb. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on the ...
Novartis8d
Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront
About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...
Callan JMB Announces Closing of $5.12 Million Initial Public Offering
The shares began trading on the Nasdaq Capital Market on February 5, 2025, under the ticker symbol “CJMB”. The Company intends to use the net proceeds of the Offering primarily for sales support, ...
Business Wire22d
Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering
LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the closing of the second tranche of its previously announced registered ...